Agios Pharmaceuticals
Agios Pharmaceuticals Logo
Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.
About Agios Pharmaceuticals
Agios Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering and developing medicines in the field of cellular metabolism, with a particular emphasis on rare diseases and hemolytic anemias. Its lead product, PYRUKYND (mitapivat), is an activator of pyruvate kinase enzymes used for the treatment of hemolytic anemias in adults with PK deficiency, and is also being developed for sickle cell disease, thalassemia, and pediatric PK deficiency. The company’s pipeline includes tebapivat for lower-risk myelodysplastic syndrome and hemolytic anemias, AG-181 for phenylketonuria (PKU), and AG-236 for polycythemia vera. Founded in 2007 and headquartered in Cambridge, Massachusetts, Agios Pharmaceuticals is committed to advancing therapies for patients with unmet medical needs through its expertise in cellular metabolism.
Address
88 Sidney Street,
Cambridge, 02139
United States
Year founded
2007
Number of employees
400-500
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Add Agios Pharmaceuticals logo and brand data to your app or website
Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.
<img src="https://img.logokit.com/agios.com" />
Report inaccurate data
Request an update to help us keep the brand up-to-date.
